LINDSAY MUSTO: Open Payments
NPI 1851649958 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 42 payments from 16 companies in 2025. Trend: 2023 $1,849 · 2024 $2,948 · 2025 $1,580
Food & beverage: $1,011Travel & lodging: $570
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $769 |
| PFIZER INC. | 9 | $149 |
| Impulse Dynamics (USA) Inc. | 2 | $149 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $114 |
| Boston Scientific Corporation | 3 | $79 |
| ABIOMED | 2 | $50 |
| Kestra Medical Technology Services, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| CORDIS US CORP. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
Products named: CARDIOMEMS, Optimizer, VYNDAQEL, LifeVest, CDS - MCT/CEM Monitoring, Assure WCD, VERQUVO, MYNX CONTROL VENOUS.
Industry payments across KY — which companies pay providers there.
